Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Immunotherapy in Allergic Rhinitis
NCT02255604Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Aug 2013
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of allergovac depot in allergic rhinitis (AR), sponsored by Aarhus University. Started Aug 2013; status: completed.
02
Drugs
allergovac depot
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02255604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255604.